Ajayi A F, Akhigbe R E
Department of Physiology, College of Medicine, Ladoke Akintola University of Technology, Ogbomoso, Oyo, Nigeria.
Reproductive Biology and Toxicology Research Laboratories, Oasis of Grace Hospital, Osogbo, Osun, Nigeria.
Heliyon. 2020 Nov 24;6(11):e05589. doi: 10.1016/j.heliyon.2020.e05589. eCollection 2020 Nov.
Several studies have implicated codeine use in the aetiopathogenesis of male infertility. The purpose of this study was to investigate the role of HER2, Ki67, oestrogen and p53/Bcl-2 signaling pathways and the possible outcome of codeine cessation on codeine-induced reproductive toxicity. Thirty adult male Wistar rats of comparable ages and weights were randomly allocated into 5 groups. The control animals received distilled water , while animals in the low-dose (LDC) and high dose (HDC) codeine-treated groups received 2 and 5 mg/kg/day of codeine respectively for 6 weeks. The animals in the low-dose codeine recovery (LDC-R) and high-dose codeine recovery (HDC-R) groups received treatment as LDC and HDC respectively followed by another drug-free six weeks, recovery period. Cessation of codeine exposure led to a partial reversal of codeine-induced poor sperm quality, reduced litter size and weight, increased oxidative testicular injury, testicular apoptosis, and testicular DNA damage caused by codeine administration. Codeine-induced gonado-spermotoxicity was associated with a reduction of circulatory testosterone, suppression of testicular HER2, Ki67, and Bcl-2 expression, down-regulation of oestrogen signaling, and upregulation of testicular caspase 3 activities and p53 signaling pathway. Conclusion: Upregulation of oestrogen signaling associated with enhanced testicular HER2 and Ki67 expression during the recovery period is seemingly beneficial in protecting against codeine-related testicular injury and infertility.
Front Reprod Health. 2023-8-2
Natl Toxicol Program Tech Rep Ser. 1996-8
Biochem Biophys Rep. 2024-12-5
Front Endocrinol (Lausanne). 2024
Histol Histopathol. 2024-6
Front Reprod Health. 2023-8-2
Reprod Biol Endocrinol. 2023-7-28
Fertil Res Pract. 2020-3-14
Oxid Med Cell Longev. 2018-7-16
Arab J Urol. 2017-12-8
Oncotarget. 2017-2-7